359 related articles for article (PubMed ID: 32579277)
1. Adropin regulates hepatic glucose production via PP2A/AMPK pathway in insulin-resistant hepatocytes.
Chen X; Chen S; Shen T; Yang W; Chen Q; Zhang P; You Y; Sun X; Xu H; Tang Y; Mi J; Yang Y; Ling W
FASEB J; 2020 Aug; 34(8):10056-10072. PubMed ID: 32579277
[TBL] [Abstract][Full Text] [Related]
2. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
3. Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation.
Zhang C; Zhang Q; Huang Z; Jiang Q
J Endocrinol; 2020 Aug; 246(2):109-122. PubMed ID: 32485680
[TBL] [Abstract][Full Text] [Related]
4. Effects of eugenol on hepatic glucose production and AMPK signaling pathway in hepatocytes and C57BL/6J mice.
Jeong KJ; Kim DY; Quan HY; Jo HK; Kim GW; Chung SH
Fitoterapia; 2014 Mar; 93():150-62. PubMed ID: 24418657
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Compound K suppresses the hepatic gluconeogenesis via activating adenosine-5'monophosphate kinase: A study in vitro and in vivo.
Wei S; Li W; Yu Y; Yao F; A L; Lan X; Guan F; Zhang M; Chen L
Life Sci; 2015 Oct; 139():8-15. PubMed ID: 26285176
[TBL] [Abstract][Full Text] [Related]
6. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
[TBL] [Abstract][Full Text] [Related]
7. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
8. The peptide hormone adropin regulates signal transduction pathways controlling hepatic glucose metabolism in a mouse model of diet-induced obesity.
Gao S; Ghoshal S; Zhang L; Stevens JR; McCommis KS; Finck BN; Lopaschuk GD; Butler AA
J Biol Chem; 2019 Sep; 294(36):13366-13377. PubMed ID: 31324719
[TBL] [Abstract][Full Text] [Related]
9. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
[TBL] [Abstract][Full Text] [Related]
10. Saponarin activates AMPK in a calcium-dependent manner and suppresses gluconeogenesis and increases glucose uptake via phosphorylation of CRTC2 and HDAC5.
Seo WD; Lee JH; Jia Y; Wu C; Lee SJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5237-42. PubMed ID: 26471090
[TBL] [Abstract][Full Text] [Related]
11. The SMILE transcriptional corepressor inhibits cAMP response element-binding protein (CREB)-mediated transactivation of gluconeogenic genes.
Lee JM; Han HS; Jung YS; Harris RA; Koo SH; Choi HS
J Biol Chem; 2018 Aug; 293(34):13125-13133. PubMed ID: 29950523
[TBL] [Abstract][Full Text] [Related]
12. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
13. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
[TBL] [Abstract][Full Text] [Related]
14. TGF-β1/Smad3 Pathway Targets PP2A-AMPK-FoxO1 Signaling to Regulate Hepatic Gluconeogenesis.
Yadav H; Devalaraja S; Chung ST; Rane SG
J Biol Chem; 2017 Feb; 292(8):3420-3432. PubMed ID: 28069811
[TBL] [Abstract][Full Text] [Related]
15. Cystathionine γ-lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.
Guo W; Li D; You Y; Li W; Hu B; Zhang S; Miao L; Xian M; Zhu Y; Shen X
FASEB J; 2019 Mar; 33(3):4212-4224. PubMed ID: 30526049
[TBL] [Abstract][Full Text] [Related]
16. PGC1A regulates the IRS1:IRS2 ratio during fasting to influence hepatic metabolism downstream of insulin.
Besse-Patin A; Jeromson S; Levesque-Damphousse P; Secco B; Laplante M; Estall JL
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4285-4290. PubMed ID: 30770439
[TBL] [Abstract][Full Text] [Related]
17. Hepatic Sam68 Regulates Systemic Glucose Homeostasis and Insulin Sensitivity.
Qiao A; Ma W; Jiang Y; Han C; Yan B; Zhou J; Qin G
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232770
[TBL] [Abstract][Full Text] [Related]
18. Vitamin K1 inversely correlates with glycemia and insulin resistance in patients with type 2 diabetes (T2D) and positively regulates SIRT1/AMPK pathway of glucose metabolism in liver of T2D mice and hepatocytes cultured in high glucose.
Dihingia A; Ozah D; Ghosh S; Sarkar A; Baruah PK; Kalita J; Sil PC; Manna P
J Nutr Biochem; 2018 Feb; 52():103-114. PubMed ID: 29175667
[TBL] [Abstract][Full Text] [Related]
19. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner.
Lee JM; Seo WY; Song KH; Chanda D; Kim YD; Kim DK; Lee MW; Ryu D; Kim YH; Noh JR; Lee CH; Chiang JY; Koo SH; Choi HS
J Biol Chem; 2010 Oct; 285(42):32182-91. PubMed ID: 20688914
[TBL] [Abstract][Full Text] [Related]
20. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
Li H; Xu M; Lee J; He C; Xie Z
Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1234-44. PubMed ID: 22967499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]